Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 274 of 1,261
  1. US 11293034

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  2. US 11291712

    Bacterial protein compositions and uses thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  3. CA 3192772

    AMELIORATION DU BIEN-ETRE PHYSIQUE ET MENTAL DE PATIENTS ATTEINTS D'HYPOPARATHYROIDISME

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Mar 31, 2022 · Expires Mar 26, 2042

    granted
  4. US 11285100

    Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections

    ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  5. US 11285194

    Combination immunotherapy approach for treatment of cancer

    Calidi Biotherapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  6. US 11286279

    Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

    The Regents of the University of California · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  7. US 11285163

    Ophthalmic solution

    SENTISS PHARMA PRIVATE LIMITED · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  8. US 11287427

    Application of anti-CD39L3 antibodies for use in disease diagnostics and imaging

    THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  9. US 11285204

    Tobamovirus-based virus-like particles and vaccines

    THE GOVERNMENT OF THE UNITED STATES, AS REPRESEN · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  10. US 11285139

    Treatment of CNS conditions

    Takeda Pharmaceutical Company Limited · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  11. US 11285175

    Targeted disruption of the MHC cell receptor

    Sangamo Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  12. US 11285153

    Substituted pyrimidine piperazine compound and use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  13. US 11285145

    Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4

    Corcept Therapeutics Incorporated · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  14. US 11285106

    Synthetic nanostructures including nucleic acids and/or other entities

    Northwestern University · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  15. US 11285142

    Compositions and methods for identifying and treating dystonia disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  16. US 11285129

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  17. US 11285169

    Methods for modulating chemotherapeutic cytotoxicity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  18. US 11286467

    System and method for production of fatty acid ethanolamides

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  19. US 11286486

    Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

    Alnylam Pharmaceuticals, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  20. US 11286528

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    BIOVERATIV THERAPEUTICS INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  21. US 11286482

    Endosomal cleavable linkers

    Alnylam Pharmaceuticals, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  22. US 11286291

    Co-stimulatory domains for use in genetically-modified cells

    Precision BioSciences, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  23. US 11286290

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  24. US 11286307

    Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

    Takeda Pharmaceutical Company Limited · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.